Cancer Treatment Related Cognitive Impairment

Course Number

This course is FREE for ALL members of, unlimited memberships start at $89/year: Become a Member

Presenter: Connie Carson, PhD, CCC-SLP
Oncology professionals, nurses, neuropsychologists, and psychologists have established cancer treatment related cognitive impairment (CTRCI) as a common side-effect of cancer treatment, impacting as many as 75% of cancer survivors; yet, speech-language pathologists have been silent in establishing their role in the treatment of this phenomenon. This presentation will provide the necessary background for them to be able to do so. Clinical symptoms will be defined and therapeutic suggestions offered. A videotape will be played of a person who received speech therapy for CTRCI, talking with a person who feels she needs it.

Upon completion of this course, participants will be able to:

  1. List at least 3 cognitive-linguistic symptoms of CTRCI “feeling in a fog”, poor
    concentration, forgetfulness, word finding problems, high level language deficits, and
    impaired executive functioning skills
  2. Identify at least 2 diagnostic tests for CTRCI FACT (Cog), Mini Mental, formal
    neuropsych evaluations, Trail Making A & B
  3. Suggest at least 2 therapeutic strategies Provide word finding strategies, memory
    compensatory skills, techniques to improve time management, and patient/family
  4. Know where to go to identify billing codes for reimbursement Know the changes in ICD-9
    and ICD-10 coding; reference the resources provided by ASHA.
About Connie: Connie Carson, Ph.D., SLP-CCC acted as a healthcare consultant and website content author to the oncology division of Nashville-based HCA, our nation’s leading provider of healthcare services. During her14-year tenure, she authored seven books and numerous articles on cancer and the importance of exercise as a vital treatment option. As a speech-language pathologist, she worked at most of the major rehabilitation centers in Denver, Colorado. Her unique background in speech-language pathology and oncology qualifies her to address the practical and theoretical cognitive deficits commonly referred to as chemo-brain but reported in the literature as Cancer Treatment Related Cognitive Impairment.  
Additional Information

This course is offered for 0.1 ASHA CEUs (Intermediate Level, Professional Area)

Course Timeline:
10 minutes: Introduction, definition of terms, statement of the problem
20 minutes: Background information; similarities between mild traumatic brain injury,
concussive syndrome, and CTRCI; diagnostic and treatment options
10 minutes: Conclusion
20 minutes: Videotaped interview with a person who had speech therapy for CTRCI

Disclosure Statement for Connie Carson:

Financial: Connie Carson is a presenter for and receives royalties. 
Nonfinancial: No relevant nonfinancial relationships exist.
Copyright © 2020 All rights reserved.
Learning Management System (LMS) is copyrighted by Copyright © 2017 Vector Solutions
114.20.547.1: JPR-OH-WEB05